Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chamomile is a **botanical drug/herbal medicine** derived from the flower heads of *Matricaria chamomilla*/*Chamomilla recutita* and used in multiple oral and topical formulations. Its pharmacology is attributed to a mixture of plant secondary metabolites, especially flavonoids and terpenoids such as apigenin, bisabolol, and chamazulene-containing constituents, which are associated with anti-inflammatory, soothing, spasmolytic, and anxiolytic effects. In the provided public sources, chamomile appears as oral extract capsules studied for chemotherapy-induced nausea and vomiting, topical gel or liposomal gel studied for prevention or management of radiation dermatitis in breast and head and neck cancer, and oral therapy studied clinically for generalized anxiety disorder. Because \"chamomile\" names a plant-derived preparation rather than one single chemically defined active substance, product composition can vary substantially by species, extraction method, concentration, and dosage form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chamomile.